AI Article Synopsis

  • A study compared the success rates and complications of using intra-cardiac echocardiography (ICE) versus transesophageal echocardiography (TEE) for guiding left atrial appendage occlusion (LAAO) procedures with a Watchmann FLX device across 26 Italian centers.
  • Both ICE and TEE groups had a 100% technical success rate and a high procedural success rate of around 98.5%, with similar outcomes for stroke and major bleeding after one year.
  • ICE had a longer procedural time but a shorter hospital stay compared to TEE, indicating that it may be equally effective but can streamline post-procedure recovery.

Article Abstract

This study aimed to compare the peri-procedural success and complication rate within a large registry of intra-cardiac echocardiography (ICE)- vs. transesophageal echocardiography (TEE)-guided left atrial appendage occlusion (LAAO) procedures with a Watchmann FLX device. Data from 772 LAAO procedures, performed at 26 Italian centers, were reviewed. Technical success was considered as the final implant of a Watchmann FLX device in LAA; the absence of pericardial tamponade, peri-procedural stroke and/or systemic embolism, major bleeding and device embolization during the procedure was defined as a procedural success. One-year stroke and major bleeding rates were evaluated as outcome. ICE-guided LAA occlusion was performed in 149 patients, while TEE was used in 623 patients. Baseline characteristics were similar between the ICE and TEE groups. The technical success was 100% in both groups. Procedural success was also extremely high (98.5%), and was comparable between ICE (98.7%) and TEE (98.5%). ICE was associated with a slightly longer procedural time (73 31 vs. 61.9 36 min, = 0.042) and shorter hospital stay (5.3 4 vs. 5.8 6 days, = 0.028) compared to the TEE group. At one year, stroke and major bleeding rates did not differ between the ICE and TEE groups. A Watchmann FLX device showed high technical and procedural success rate, and ICE guidance does not appear inferior to TEE.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607018PMC
http://dx.doi.org/10.3390/jcm12206658DOI Listing

Publication Analysis

Top Keywords

flx device
16
watchmann flx
12
major bleeding
12
procedural success
12
left atrial
8
atrial appendage
8
appendage occlusion
8
laao procedures
8
technical success
8
stroke major
8

Similar Publications

Association of Physician Certification and Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion.

JACC Cardiovasc Interv

October 2024

Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA; Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, CT, USA.

Article Synopsis
  • The study examines outcomes of percutaneous left atrial appendage occlusion (LAAO) procedures performed by either electrophysiologists (EPs) or interventional cardiologists (ICs) between 2020 and 2022, focusing on patient safety and complications.
  • Key findings indicate that EPs utilized intracardiac echocardiography more frequently and achieved lower radiation exposure; however, rates of major adverse events (MAE) and in-hospital mortality were comparable between the two groups.
  • Overall, LAAO was deemed safe with no significant differences in outcomes based on operator certification, highlighting the importance of continued use of these techniques by both specialties for broader patient access.
View Article and Find Full Text PDF

Introduction: Real-world studies comparing safety and efficacy of combined percutaneous left atrial appendage occlusion (LAAO) and catheter ablation (CA) to LAAO alone are limited.

Methods: Patients from a large US hospital system undergoing combined LAAO and left-atrial CA from 8/2020 to 2/2024 were retrospectively analyzed and compared to a control group undergoing LAAO alone. Controls were identified using a 1:2 propensity score match based on LAAO device type (Watchman FLX vs.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness and safety of using a 3D computational model fused with real-time fluoroscopy to guide left atrial appendage closure (LAAC) for patients with non-valvular atrial fibrillation.
  • The research included 106 patients who underwent the procedure, achieving a 100% success rate for device implantation and meeting primary efficacy criteria in 89% of cases.
  • The approach was deemed safe, with only 1.9% of patients experiencing major complications, suggesting that this technique could enhance LAAC outcomes.
View Article and Find Full Text PDF

Tissue oedema following pulsed field ablation recognized during a concomitant left atrial appendage closure procedure: a case report.

Eur Heart J Case Rep

September 2024

Cardioangiologisches Centrum Bethanien (CCB) Frankfurt am Main, Medizinische Klinik III, Agaplesion Markus Krankenhaus, Wilhelm-Epstein-Straße 4, 60431, Frankfurt am Main, Germany.

Article Synopsis
  • In patients with non-valvular atrial fibrillation at high stroke risk who can't take long-term anticoagulants, left atrial appendage closure (LAAC) serves as an alternative treatment.
  • A case study of a 74-year-old female highlighted the successful use of pulsed field ablation (PFA) for pulmonary vein isolation (PVI) along with LAAC using the WATCHMAN FLX™ device.
  • Follow-up showed no stroke or bleeding incidents over 6 months, with an initial swelling around the LAAC device resolving and a stable, albeit slightly tilted, device position without leakage.
View Article and Find Full Text PDF

Background: Left atrial appendage occlusion (LAAO) is an alternative to anticoagulation for stroke prevention in select patients with atrial fibrillation (AF). In this study, we describe the case of a patient with delayed device-related thrombus (DRT) at 13 months post-LAAO in a setting of atrial stasis due to a worsening mitral bioprosthetic stenosis.

Case Summary: A 69-year-old woman with a history of rheumatic mitral stenosis and regurgitation post-bioprosthetic mitral valve replacement (6 years prior) and paroxysmal AF was referred for percutaneous LAAO due to recurrent severe gastrointestinal bleeding while on anticoagulation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!